{"id":"NCT01252732","sponsor":"Melinta Therapeutics, Inc.","briefTitle":"Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection","officialTitle":"A Multicenter, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Single-Dose IV Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection (SOLO II)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-12","primaryCompletion":"2013-06","completion":"2013-06","firstPosted":"2010-12-03","resultsPosted":"2021-04-13","lastUpdate":"2021-05-05"},"enrollment":1019,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Wound Infection","Abscess","Systemic Inflammation","Cellulitis"],"interventions":[{"type":"DRUG","name":"Single-Dose IV Oritavancin Diphosphate","otherNames":[]},{"type":"DRUG","name":"IV Vancomycin","otherNames":[]}],"arms":[{"label":"Single-Dose IV Oritavancin Diphosphate","type":"EXPERIMENTAL"},{"label":"IV Vancomycin","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this Phase 3 trial is to evaluate the efficacy, safety, and tolerability of oritavancin in ABSSSIs, including those caused by MRSA and to evaluate the potential economic benefit of oritavancin administered as a single 1200 mg IV dose.","primaryOutcome":{"measure":"Early Clinical Response","timeFrame":"48-72 hours after the initation of study therapy","effectByArm":[{"arm":"Single-Dose 1200 mg Oritavancin","deltaMin":403,"sd":null},{"arm":"Vancomycin","deltaMin":416,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["29358292","27370913","25294250"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":22,"n":503},"commonTop":["nausea","headache","vomiting","pruritus","cellulitis"]}}